MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Sales of property andequipment and other assets$20K Net increase(decrease) in cash and cash...-$12,967K Net cash provided by(used in) investing...$20K Net gain on leasetermination$633K Prepaid expenses andother current assets,...$53K Net increase(decrease) in cash and cash...-$12,967K Canceled cashflow$20K Accounts payable$197K Depreciation Depletion AndAmortization$129K Prepaid research anddevelopment-$107K Canceled cashflow$556K Net cash provided by(used in) operating...-$12,987K Canceled cashflow$433K Sharebased compensation$556K Net Income Loss-$7,600K Right of use assets andoperating lease...$4,973K Accrued expenses andother current...-$758K Net gain on leasetermination$600K
Cash Flow

Passage BIO, Inc. (PASG)

Passage BIO, Inc. (PASG)

source: myfinsight.com